Follow the Assertio Holdings, Inc. stock price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Operating in the Health Care sector, Assertio Holdings, Inc. has recorded 139 reports. Market capitalisation: €151.9m. The latest transaction was filed on 16 June 2026 (U). Among the most active insiders: Patel Ajay. The full history is openly available.
139
Insider Decl.
0
Thresholds
€183,692
10 ops.
Buy Volume
€2m
12 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Assertio Holdings, Inc. Buy (bullish), based on 3 analysts. Average price target: US$24.43.
36Σ signal
Buys €183,692€2m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 24,066 of 25,567 companies
17.1
score / 100
Value
8
Quality
27
FCF yld-19%
Earn yld-20%
EV/EBITDA50.1x
ROE-39%
Gross mgn70%
Net mgn-26%
Debt/EBITDA10.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Assertio Holdings, Inc. is a company focused on the development and commercialization of pharmaceutical products. It is listed on the NASDAQ under the ticker ASRT.